IMDX

Insight Molecular Diagnostics
IMDX

Overview Fund Trends Analyst Outlook Journalist POV

30 hedge funds and large institutions have $14.3M invested in Insight Molecular Diagnostics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more funds holding in top 10

Funds holding in top 10: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

36% less funds holding

Funds holding: 47 → 30 (-17)

81% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 21

Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$69K
2
+$32.8K
3
+$16.5K
4
State Street
State Street
Massachusetts
+$7.21K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$2.51K

Top Sellers

1
-$72.2K
2
-$57.9K
3
-$44.8K
4
LPL Financial
LPL Financial
California
-$29.3K
5
VF
Virtu Financial
New York
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$22
27
$12
28
$3
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
1
2